Open Access
CC BY 4.0 · Rev Bras Ortop (Sao Paulo) 2024; 59(06): e922-e935
DOI: 10.1055/s-0044-1790578
Artigo Original
Ortopedia Pediátrica

The Peritubercle Lucency Sign as a Considerable Predictive Factor for Contralateral Hip Slippage in Unilateral Slipped Capital Femoral Epiphysis Cases

Artikel in mehreren Sprachen: português | English
Anastácio Kotzias Neto
1   Departamento de Ortopedia Pediátrica, Hospital Infantil Joana de Gusmão, Florianópolis, SC, Brasil
,
1   Departamento de Ortopedia Pediátrica, Hospital Infantil Joana de Gusmão, Florianópolis, SC, Brasil
,
Marthina Alice Gressler
1   Departamento de Ortopedia Pediátrica, Hospital Infantil Joana de Gusmão, Florianópolis, SC, Brasil
,
Marco Aurélio de Oliveira
1   Departamento de Ortopedia Pediátrica, Hospital Infantil Joana de Gusmão, Florianópolis, SC, Brasil
› Institutsangaben


Financial Support The authors declare that they did not receive financial support from agencies in the public, private, or non-profit sectors to conduct the present study.
Preview

Abstract

Objective To determine whether the radiographic parameter at the epiphyseal tubercle region (peritubercle lucency sign) on the unaffected side can predict slipped capital femoral epiphysis (SCFE).

Methods We retrospectively reviewed patients who received an initial diagnosis of unilateral SCFE between 1995 and 2020 at a pediatric hospital in a Brazilian state's capital. The patients were monitored for at least 18 months. Two reviewers independently and blindly assessed the radiographs for the presence or absence of the sign. Disagreements were resolved by a third senior reviewer.

Results Out of the 115 cases reviewed, the peritubercle lucency sign was observed in 21 of the 30 patients who developed the disease in the contralateral hip. The sign was observed on an average of 21 days after the diagnosis on the initial side, and approximately 301 days prior to the condition affecting the contralateral hip. It was present in 95% and 85% of the cases on the lateral (frog-leg) and anteroposterior (AP) views, respectively. Interobserver reliability was measured using the Kappa test (k = 0.0801). There was a significant relationship between the presence of the sign and SCFE (p < 0.001).

Conclusions: We propose that the peritubercle lucency sign can be used as a supplementary tool in early diagnosis, for it is beneficial in the therapeutic planning.

Level Of Evidence: Level III – Diagnostic Study In Nonconsecutive Patients (Without Consistently Applied ‘Gold Standard’ As Reference)

Author Contributions:

Each author contributed individually and significantly to the development of this research. AK: development of the research project, evaluator 3, writing of the article, and text review; RVRM: development of the research project, evaluator 1, writing of the article, text review, and bibliographical review; MAG: development of the research project, evaluator 2, writing of the article, and literature review; and MAO: development of the research project, search of records and radiographs and writing of the article.


Work carried out at the Department of Pediatric Orthopedics, Hospital Infantil Joana de Gusmão, Florianópolis, SC, Brazil.




Publikationsverlauf

Eingereicht: 20. März 2024

Angenommen: 23. Juni 2024

Artikel online veröffentlicht:
21. Dezember 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil